Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Bifurcation Lesions Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of coronary artery diseases globally
5.1.1.2. Rising elderly population and the medical ailments associated with age
5.1.1.3. Improving healthcare infrastructure coupled with preference for minimally invasive surgeries
5.1.2. Restraints
5.1.2.1. Lack of skilled professional in the industry
5.1.3. Opportunities
5.1.3.1. Ongoing research and development toward introduction novel treatment techniques
5.1.3.2. Surge in the number of clinical trials on balloons and stents
5.1.4. Challenges
5.1.4.1. Stringent regulations and standards
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Bifurcation Lesions Market, by Type
6.1. Introduction
6.2. One-Stent
6.3. Two-Stent

7. Bifurcation Lesions Market, by Application
7.1. Introduction
7.2. Coronary Vascular
7.3. Peripheral Vascular

8. Americas Bifurcation Lesions Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Bifurcation Lesions Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Bifurcation Lesions Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Absolute-DSi
12.1.3. B. Braun SE
12.1.4. Becton, Dickinson and Company
12.1.5. BIOTRONIK SE & Co. KG
12.1.6. Boston Scientific Corporation
12.1.7. Cardinal Health Inc.
12.1.8. Cook Group Incorporated
12.1.9. Johnson & Johnson Services, Inc.
12.1.10. Koninklijke Philips N.V.
12.1.11. Medtronic PLC
12.1.12. MicroPort Scientific Corporation
12.1.13. Olympus Corporation
12.1.14. Stryker Corporation
12.1.15. Tecomet, Inc.
12.1.16. Terumo Corporation
12.1.17. Tryton Medical, Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. BIFURCATION LESIONS MARKET RESEARCH PROCESS
FIGURE 2. BIFURCATION LESIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. BIFURCATION LESIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIFURCATION LESIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIFURCATION LESIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIFURCATION LESIONS MARKET DYNAMICS
FIGURE 7. BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. BIFURCATION LESIONS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. BIFURCATION LESIONS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BIFURCATION LESIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. BIFURCATION LESIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIFURCATION LESIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. BIFURCATION LESIONS MARKET SIZE, BY ONE-STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIFURCATION LESIONS MARKET SIZE, BY TWO-STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. BIFURCATION LESIONS MARKET SIZE, BY CORONARY VASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BIFURCATION LESIONS MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. BRAZIL BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. CANADA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. CANADA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. MEXICO BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. MEXICO BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES BIFURCATION LESIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AUSTRALIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CHINA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CHINA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. INDIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. INDIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. INDONESIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. JAPAN BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. JAPAN BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MALAYSIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. PHILIPPINES BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. SINGAPORE BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. SOUTH KOREA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. TAIWAN BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. THAILAND BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. THAILAND BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. VIETNAM BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA BIFURCATION LESIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. DENMARK BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. DENMARK BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. EGYPT BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. EGYPT BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. FINLAND BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. FINLAND BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. FRANCE BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. FRANCE BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. GERMANY BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. GERMANY BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ISRAEL BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ITALY BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. ITALY BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. NETHERLANDS BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. NIGERIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. NORWAY BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. NORWAY BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. POLAND BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. POLAND BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. QATAR BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. QATAR BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SPAIN BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SPAIN BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SWEDEN BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SWITZERLAND BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. TURKEY BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. TURKEY BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM BIFURCATION LESIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM BIFURCATION LESIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. BIFURCATION LESIONS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 98. BIFURCATION LESIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 99. BIFURCATION LESIONS MARKET LICENSE & PRICING